• Mashup Score: 0
    Make Your Own Rules: Dr. Michelle Kittleson - American College of Cardiology - 2 year(s) ago

    Interviewer: Francis Alenghat, MD, PhD, University of Chicago Michelle Kittleson, MD, PhD, FACCProfessor of Medicine at Cedars-Sinai, Director of Education in Heart Failure and Transplantation, and Director of Heart Failure Research at the Smidt Heart Institute. Describe what you do on a day-to-day basis in your current roles. As a heart failure transplant cardiologist at Cedar Sinai, I spend…

    Source: American College of Cardiology
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of alenghat
      alenghat

      For the answer and the rest of the interview with @MKIttlesonMD for @ACCinTouch #ACCAcademic click here: https://t.co/PsEt01xqUi

  • Mashup Score: 0
    Illinois Chapter ACC - - 2 year(s) ago

    Our mission is to promote optimal cardiovascular care and disease prevention through public and professional education, promotion of research, leadership in the development of standards and guidelines and the formulation of health care policy. FIT Poster Presentation April 21, 2022 6:30pm – 9:00pmFlyer Register Midwest ACC Women In Cardiology…

    Source: www.ilacc.org
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of alenghat
      alenghat

      Go here to register and submit for the Apr 21 Illinois ACC FIT poster session ➡️➡️https://t.co/idCSl2Jobm Abstracts due Apr 11 https://t.co/XvtmSk35tN

  • Mashup Score: 0
    Short Interfering RNA Targeting Lp(a) Production in Individuals With Elevated Plasma Lp(a) - 2 year(s) ago

    This phase 1 study evaluated the safety and tolerability of 4 different doses of a short interfering RNA designed to reduce hepatic production of apolipoprotein(a) and assessed associated changes in plasma concentrations of lipoprotein(a), compared with placebo, among individuals with elevated…

    Source: jamanetwork.com
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mividovich
      mividovich

      Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels #ACC22 ⁦@ACCinTouch⁩ #LP(a) https://t.co/riKOPupksw

    • Profile photo of alenghat
      alenghat

      Nissen now presenting APOLLO on siRNA therapy to suppress translation of Lp(a) for 32 people with Lp(a)>150nmol/L (median 224). phase 1. in addition to marked Lp(a) lowering, also reduced LDL a bit. #ACC22 https://t.co/joHJPHKKcw https://t.co/ZLEpVtDNWM

  • Mashup Score: 2
    Welcome | ACC.22 - American College of Cardiology - 2 year(s) ago

    Welcome to ACC.22 Virtual! Connect with your colleagues, see the latest science and innovation, and learn practice-changing updates in care. At ACC.22, you’ll get access to clinically focused sessions with opportunities to ask top experts your questions. ACC.22 Virtual offers a world-class program delivered through…

    Source: virtual.acc.org
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of alenghat
      alenghat

      “Optimizing Your Research Tools: Exploring the Hypothesis Beyond Clinical Trials!” here virtually #ACC22. It was great to participate in this session w/ Natalie Jayaram, @kewatson, @ericjvelazquez & @ErinMichos. Take a look! https://t.co/aHZca5Awua #ACCAcademic @ACCinTouch https://t.co/gJnvyryKBk

Load More